{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:33:18Z","timestamp":1775593998927,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Argentina de Microbiolog\u00eda"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ram.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T11:27:29Z","timestamp":1760354849000},"page":"156-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial susceptibility of Clostridioides difficile. An Argentinian multicenter study of isolates from human patients"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-741X","authenticated-orcid":false,"given":"Raquel","family":"Rollet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Vaustat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirta","family":"Litterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Castello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Fern\u00e1ndez-Canigia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Barberis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cristina","family":"Legaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Azula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Laura","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Laube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Carla","family":"Predari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Adelaida","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ram.2025.09.006_bib0250","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01259-19","article-title":"Antimicrobial susceptibility and molecular characterization using whole-genome sequencing of Clostridioides difficile collected in 82 hospitals in Japan between 2014 and 2016","volume":"63","author":"Aoki","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2025.09.006_bib0255","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/pathogens11080949","article-title":"Antibiotic resistance profile of RT 027\/176 versus other Clostridioides difficile isolates in Silesia, Southern Poland","volume":"11","author":"Aptekorz","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ram.2025.09.006_bib0260","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/jam.14035","article-title":"Highly antibiotic-resistant Clostridium difficile isolates from Iranian patients","volume":"125","author":"Baghani","year":"2018","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0265","first-page":"1","article-title":"Recomendaciones intersociedades para diagn\u00f3stico, tratamiento y prevenci\u00f3n de las infecciones por Clostridioides difficile","volume":"80","author":"Barc\u00e1n","year":"2020","journal-title":"Medicina (Buenos Aires)"},{"key":"10.1016\/j.ram.2025.09.006_bib0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkac404","article-title":"Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA\/SHEA, ESCMID and ASID guidelines","volume":"78","author":"Bishop","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ram.2025.09.006_bib0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.37201\/req\/2065.2020","volume":"33","author":"Bouza","year":"2020","journal-title":"Rev Esp Quim"},{"key":"10.1016\/j.ram.2025.09.006_bib0280","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12879-014-0607-z","article-title":"Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich","volume":"14","author":"B\u00fcchler","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0285","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-micro-090110-102824","article-title":"Biology of Clostridium difficile: implications for epidemiology and diagnosis","volume":"65","author":"Carroll","year":"2011","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0290","series-title":"Performance standards for antimicrobial susceptibility testing. Document M100. Wayne, EE.UU.","year":"2019"},{"key":"10.1016\/j.ram.2025.09.006_bib0295","series-title":"Performance standards for antimicrobial susceptibility testing. Document M100. Wayne, PA, EE.UU.","year":"2023"},{"key":"10.1016\/j.ram.2025.09.006_bib0300","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00489-22","article-title":"Influence of binary toxin gene detection and decreased susceptibility to antibiotics among Clostridioides difficile strains on disease severity: a single-center study","volume":"66","author":"Costa","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2025.09.006_bib0305","first-page":"73","article-title":"Clostridioides difficile: characterization of the circulating toxinotypes in an Argentinean public hospital","volume":"55","author":"Crivaro","year":"2023","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262597","article-title":"Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: a systematic review and meta-analysis","volume":"17","author":"Dilnessa","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ram.2025.09.006_bib0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anaerobe.2014.08.002","article-title":"Investigation of the MICs of fidaxomicin and other antibiotics against Hungarian Clostridium difficile isolates","volume":"31","author":"Eitel","year":"2015","journal-title":"Anaerobe"},{"key":"10.1016\/j.ram.2025.09.006_bib0320","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Anaerobic bacteria. Version 13.0, valid from 2023-01-01."},{"key":"10.1016\/j.ram.2025.09.006_bib0325","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Anaerobic bacteria. Version 9.0, valid from 2019-01-01."},{"key":"10.1016\/j.ram.2025.09.006_bib0330","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bjid.2016.07.004","article-title":"Antimicrobial susceptibility of Brazilian Clostridium difficile strains determined by agar dilution and disk diffusion","volume":"20","author":"Fraga","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.09.017","article-title":"Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes","volume":"21","author":"Freeman","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ram.2025.09.006_bib0340","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmi.2017.10.008","article-title":"The ClosER study: results from a three-year Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011\u20132014","volume":"24","author":"Freeman","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ram.2025.09.006_bib0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10096-019-03708-7","article-title":"Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study","volume":"39","author":"Freeman","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0350","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/cid\/ciac817","article-title":"Reference susceptibility testing and genomic surveillance of Clostridioides difficile United States, 2012\u20137","volume":"76","author":"Gargis","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0355","first-page":"496","article-title":"Antibiotic susceptibility profile of Clostridium difficile bacteria isolated from older residents of a nursing home in Iran","volume":"15","author":"Ghasemi","year":"2021","journal-title":"Iran J Ageing"},{"key":"10.1016\/j.ram.2025.09.006_bib0360","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1469-0691.2009.02759.x","article-title":"Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina","volume":"15","author":"Goorhuis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ram.2025.09.006_bib0365","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3201\/eid2404.170095","article-title":"Imipenem resistance in Clostridium difficile ribotype 017, Portugal","volume":"24","author":"Isidro","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0370","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab718","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0375","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0380","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijid.2022.09.013","article-title":"Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?","volume":"124","author":"Krutova","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0385","first-page":"51","article-title":"Primer consenso argentino para el estudio de la sensibilidad in vitro a los antimicrobianos de las bacterias anaerobias de importancia cl\u00ednica en humanos","volume":"43","author":"Legaria","year":"2011","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0390","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00296-20","article-title":"Antimicrobial susceptibilities of Clostridium difficile isolates from 12 Asia-Pacific countries in 2014 and 2015","volume":"64","author":"Lew","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2025.09.006_bib0395","series-title":"Sensibilidad antibi\u00f3tica de Clostridium difficile aislados en un hospital pedi\u00e1trico","author":"Litterio","year":"2014"},{"key":"10.1016\/j.ram.2025.09.006_bib0400","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bjid.2014.07.004","article-title":"Epidemiology of Clostridium difficile: a hospital-based descriptive study in Argentina and Mexico","volume":"19","author":"Lopardo","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0405","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijid.2018.04.3691","article-title":"Clostridium difficile susceptibility profiles to vancomycin and metronidazol in a pediatric population","volume":"73S","author":"Maldonado","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0410","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/11534490-000000000-00000","article-title":"Anaerobic infections. Update on treatment considerations","volume":"70","author":"Nagy","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.ram.2025.09.006_bib0415","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s10096-021-04311-5","article-title":"Antimicrobial resistance in Clostridioides difficile","volume":"40","author":"O\u2019Grady","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0420","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/JCM.00524-08","article-title":"Metronidazole resistance in Clostridium difficile is heterogeneous","volume":"46","author":"Pel\u00e1ez","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0425","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1099\/jmm.0.029801-0","article-title":"Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004\u20132006","volume":"60","author":"Pituch","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0430","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.anaerobe.2017.10.002","article-title":"Rifaximin-resistant Clostridium difficile strains isolated from symptomatic patients","volume":"48","author":"Reigadas","year":"2017","journal-title":"Anaerobe"},{"issue":"Suppl. 1","key":"10.1016\/j.ram.2025.09.006_bib0435","first-page":"56","article-title":"Clostridium difficile. Su sensibilidad in vitro frente a antibi\u00f3ticos de amplio uso en un hospital de enfermedades infecciosas. VII Congreso de la Sociedad Argentina de Bacteriolog\u00eda, Micolog\u00eda y Parasitolog\u00eda Cl\u00ednicas. SADEBAC 2012, Abstract P127","volume":"44","author":"Rollet","year":"2012","journal-title":"Rev Argent Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.ram.2025.09.006_bib0440","first-page":"7","article-title":"Clostridium difficile: su comportamiento in vitro frente a metronidazol. XIII Congreso Argentino de Microbiolog\u00eda. II Congreso Microbiolog\u00eda Agr\u00edcola y Ambiental 2013, Abstract O-005","volume":"45","author":"Rollet","year":"2013","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.ram.2025.09.006_bib0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.anaerobe.2019.102072","article-title":"Increasing antibiotic resistance in Clostridioides difficile: a systematic review and meta-analysis","volume":"58","author":"Saha","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.ram.2025.09.006_bib0450","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13756-020-00815-5","article-title":"Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis","volume":"9","author":"Sholeh","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ram.2025.09.006_bib0455","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/jac\/dkr292","article-title":"Multidrug resistance in European Clostridium difficile clinical isolates","volume":"66","author":"Spigaglia","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ram.2025.09.006_bib0460","first-page":"23","article-title":"Recent advances in the understanding of antibiotics resistance in Clostridium difficile infection","volume":"3","author":"Spigaglia","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.ram.2025.09.006_bib0465","doi-asserted-by":"crossref","first-page":"37865","DOI":"10.1038\/srep37865","article-title":"The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis","volume":"6","author":"Tang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ram.2025.09.006_bib0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jgar.2017.04.005","article-title":"Antimicrobial susceptibility of Clostridium difficile isolates in Israel","volume":"10","author":"Tkhawkho","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ram.2025.09.006_bib0475","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clinical Microbiol Infect"},{"key":"10.1016\/j.ram.2025.09.006_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2012.01.004","article-title":"Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence","volume":"40","author":"Vardakas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 1","key":"10.1016\/j.ram.2025.09.006_bib0485","first-page":"13","article-title":"Sensibilidad a vancomicina y metronidazol de aislamientos de Clostridium difficile procedentes de pacientes asistidos en el hospital F.J. Mu\u00f1iz. 3\u00b0 Congreso de Enfermedades Endemoepid\u00e9micas. Hospital de Infecciosas \u201cF.J. Mu\u00f1iz\u201d. A\u00f1o 14","author":"Vaustat","year":"2011","journal-title":"El Mu\u00f1iz Hoy"},{"key":"10.1016\/j.ram.2025.09.006_bib0490","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijid.2017.07.010","article-title":"Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China","volume":"67","author":"Wang","year":"2018","journal-title":"Int J Infect Dis"}],"container-title":["Revista Argentina de Microbiolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:53:34Z","timestamp":1774580014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0325754125000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0325754125000999"],"URL":"https:\/\/doi.org\/10.1016\/j.ram.2025.09.006","relation":{},"ISSN":["0325-7541"],"issn-type":[{"value":"0325-7541","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of Clostridioides difficile. An Argentinian multicenter study of isolates from human patients","name":"articletitle","label":"Article Title"},{"value":"Revista Argentina de Microbiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ram.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Argentina de Microbiolog\u00eda.","name":"copyright","label":"Copyright"}]}}